SCHEMBL21279520

SCHEMBL21279520

CC(C)(C)OC(=O)N1CCCCC1c1cn2nc(Cl)ccc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 8/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ LMNA P02545 4/20 0.40
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ HTT P42858 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ CRHBP P24387 1/20 0.37
▸ CRHR2 Q13324 1/20 0.37
▸ ALOX5 P09917 1/20 0.37
▸ NAMPT P43490 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ EPHA2 P29317 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ EPHB4 P54760 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15317023 1.00 TSHR (0.40) TSHRALDH1A1LMNAMEN1KMT2A
SCHEMBL15317025 0.83 ALDH1A1 (0.38) TSHRALDH1A1LMNAMEN1KMT2A
SCHEMBL21279646 0.83 ALDH1A1 (0.38) TSHRALDH1A1LMNAMEN1KMT2A
SCHEMBL21279624 0.82 LMNA (0.38) TSHRALDH1A1LMNAMEN1KMT2A
SCHEMBL15317028 0.82 LMNA (0.38) TSHRALDH1A1LMNAMEN1KMT2A
SCHEMBL3140490 0.79 NPC1 (0.53) ALDH1A1LMNAMEN1KMT2ANPSR1
SCHEMBL3138175 0.79 NPC1 (0.53) ALDH1A1LMNAMEN1KMT2ANPSR1
SCHEMBL3138170 0.79 NPC1 (0.53) ALDH1A1LMNAMEN1KMT2ANPSR1
SCHEMBL3137872 0.79 KDM1A (0.39) ALDH1A1NAMPTKDR
SCHEMBL15957797 0.78 TSHR (0.39) TSHRALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2838900-B1 COMPOUNDS AND METHODS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES INC (US) 2019-08-21 — — EP disclosed
Send feedback